The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.

[1]  P. Workman,et al.  The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554. , 1996, Anti-cancer drug design.

[2]  R. Hill,et al.  Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay. , 1996, Radiation research.

[3]  P. Workman,et al.  Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel fluorinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasma. , 1995, Journal of chromatography. B, Biomedical applications.

[4]  P. Workman,et al.  The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis. , 1995, British Journal of Cancer.

[5]  J. Evelhoch,et al.  The effects of isoflurane and halothane on blood flow and 31P NMR spectra in murine RIF‐1 tumors , 1995, Magnetic resonance in medicine.

[6]  C. Grau,et al.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. , 1994, International journal of radiation oncology, biology, physics.

[7]  P. Workman,et al.  Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. , 1994, International journal of radiation oncology, biology, physics.

[8]  P. Wood,et al.  31P MRS of tumour metabolism in anaesthetized vs conscious mice , 1994, NMR in biomedicine.

[9]  J. D. Chapman,et al.  The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles. , 1994, International journal of radiation oncology, biology, physics.

[10]  L. Harwell,et al.  Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. , 1993, Cancer research.

[11]  P Okunieff,et al.  Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. , 1993, International journal of radiation oncology, biology, physics.

[12]  P. Olive,et al.  Misonidazole binding in SCCVII tumors in relation to the tumor blood supply. , 1989, International journal of radiation oncology, biology, physics.

[13]  R. Gatenby,et al.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. , 1988, International journal of radiation oncology, biology, physics.

[14]  C. Koch,et al.  Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. , 1987, Cancer research.

[15]  C. Koch,et al.  Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration. , 1984, International journal of radiation oncology, biology, physics.

[16]  J. D. Chapman,et al.  Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. , 1983, Cancer research.

[17]  J. D. Chapman,et al.  A marker for hypoxic cells in tumours with potential clinical applicability. , 1981, British Journal of Cancer.

[18]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[19]  J. Overgaard.  Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. , 1980, British Journal of Cancer.

[20]  C. Grau,et al.  Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model. , 1995, Acta oncologica.

[21]  M. Horsman,et al.  Tumor blood flow changes induced by chemical modifiers of radiation response. , 1992, International journal of radiation oncology, biology, physics.

[22]  P. Okunieff,et al.  Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients. , 1992, Advances in experimental medicine and biology.

[23]  L. Kwock,et al.  Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry. , 1992, Radiation research.

[24]  P Vaupel,et al.  Pathophysiological approaches to identifying tumor hypoxia in patients. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  J. Raleigh,et al.  Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy. , 1990, International journal of radiation biology.

[26]  P Kolstad,et al.  Intercapillary distance, oxygen tension and local recurrence in cervix cancer. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.